×
About 3,708 results

ALLMedicine™ Hypoparathyroidism Center

Research & Reviews  1,625 results

Intraoperative parathyroid hormone measurement facilitates outpatient thyroidectomy in ...
https://doi.org/10.1016/j.amjsurg.2021.02.009
American Journal of Surgery; Obiarinze R, Fazendin J et. al.

Mar 2nd, 2021 - We hypothesize that intraoperative parathyroid hormone (ioPTH) measurement after a total thyroidectomy predicts children at risk for hypoparathyroidism and allow for outpatient procedure. Between 2015 and 2019, we reviewed all patients under the a...

What are the real rates of temporary hypoparathyroidism following thyroidectomy? It is ...
https://doi.org/10.1007/s12020-021-02663-8 10.1007/s13304-017-0475-3 10.1016/j.surg.2014.09.007 10.1007/s12020-019-01858-4 10.1089/thy.2017.0309 10.1530/EJE-15-0628 10.12659/MSM.892867 10.1002/jso.24159 10.1007/s12020-019-02014-8 10.1016/j.anl.2018.04.008 10.1111/j.1445-2197.2010.05633.x 10.1007/s00423-015-1292-0 10.1016/j.ijsu.2016.08.010 10.1186/1477-7819-12-200 10.1007/s00268-012-1809-4 10.1016/j.asjsur.2015.11.005 10.1007/s00268-012-1843-2 10.1007/s12020-018-1601-9 10.1530/EJE-17-0589 10.1016/j.surg.2015.04.041 10.1016/j.ijsu.2015.04.074 10.1007/s00268-014-2571-6 10.1007/s00268-019-04987-z 10.1016/j.jss.2015.04.059 10.1002/hed.23937 10.1177/0194599814521365 10.1016/j.amjsurg.2013.01.038 10.1007/s12020-020-02310-8 10.1016/j.anorl.2013.11.009 10.1016/j.jpedsurg.2019.06.027 10.1016/j.surg.2012.08.056 10.1007/s00268-019-05231-4 10.1016/j.jpedsurg.2017.01.011 10.1016/j.jss.2020.02.018 10.1007/s00268-020-05514-1 10.1016/j.endinu.2018.08.006 10.1007/s00268-019-05125-5 10.1001/jamaoto.2016.3670 10.1007/s00423-016-1386-3 10.1002/bjs.10086 10.1515/jpem-2015-0333 10.1007/s00268-014-2622-z 10.1016/j.amjsurg.2013.11.007 10.1111/j.1445-2197.2005.03435.x 10.1016/j.surg.2017.12.025 10.1007/s00595-020-02065-9
Endocrine Koimtzis GD, Stefanopoulos L et. al.

Mar 2nd, 2021 - Post-operative hypoparathyroidism is the most encountered complication of thyroid surgery and is classified as temporary or permanent. However, its incidence varies greatly in the literature ranging from 0.5% to 65%. This can be mainly attributed ...

Renal complications in patients with chronic hypoparathyroidism on conventional therapy...
https://doi.org/10.1007/s11154-020-09613-1 10.1016/j.ecl.2018.07.012 10.1056/NEJMcp0803050 10.1359/jbmr.080803 10.1002/jbmr.1979 10.1002/jbmr.2501 10.1002/jbmr.3368 10.1210/jc.2015-2257 10.7326/0003-4819-151-4-200908180-00135 10.1007/s00467-009-1116-y 10.3389/fped.2018.00098 10.1038/ki.2015.76 10.4158/EP13328.OR 10.1007/s40618-018-0857-5 10.1055/s-0042-118181 10.1210/jc.2016-1477 10.1148/radiol.2221010453 10.2215/CJN.02610319
Reviews in Endocrine & Metabolic Disorders; Gosmanova EO, Houillier P et. al.

Feb 18th, 2021 - A systematic literature review was performed to summarize the frequency and nature of renal complications in patients with chronic hypoparathyroidism managed with conventional therapy. Methodology was consistent with the recommendations outlined i...

Postsurgical hypoparathyroidism - current treatments and future prospects for parathyro...
https://doi.org/10.1530/EJE-20-1367
European Journal of Endocrinology; Mihai R, Thakker RV

Feb 18th, 2021 - Permanent post-surgical hypoparathyroidism (POSH) is a major complication of anterior neck surgery in general and of thyroid surgery in particular. Depending of diagnostic criteria, up to 10% of patients undergoing bilateral thyroid surgery develo...

see more →

Guidelines  5 results

Management of immune-related adverse events in endocrine organs induced by immune check...
https://doi.org/10.1507/endocrj.EJ19-0163
Endocrine Journal; Arima H, Iwama S et. al.

Jun 27th, 2019 - Immune checkpoint inhibitors (ICIs) have become a promising treatment for advanced malignancies. However, these drugs can induce immune-related adverse events (irAEs) in several organs, including skin, gastrointestinal tract, liver, muscle, nerve,...

American Thyroid Association Statement on Postoperative Hypoparathyroidism: Diagnosis, ...
https://doi.org/10.1089/thy.2017.0309
Thyroid : Official Journal of the American Thyroid Associ... Orloff LA, Wiseman SM et. al.

May 31st, 2018 - Hypoparathyroidism (hypoPT) is the most common complication following bilateral thyroid operations. Thyroid surgeons must employ strategies for minimizing and preventing post-thyroidectomy hypoPT. The objective of this American Thyroid Association...

Diagnosis and treatment of hypoparathyroidism: a position statement from the Brazilian ...
https://doi.org/10.20945/2359-3997000000015
Archives of Endocrinology and Metabolism; Maeda SS, Moreira CA et. al.

Apr 25th, 2018 - Objective To present an update on the diagnosis and treatment of hypoparathyroidism based on the most recent scientific evidence. Materials and methods The Department of Bone and Mineral Metabolism of the Sociedade Brasileira de Endocrinologia e M...

European Society of Endocrinology Clinical Guideline: Treatment of chronic hypoparathyr...
https://doi.org/10.1530/EJE-15-0628
European Journal of Endocrinology; Bollerslev J, Rejnmark L et. al.

Jul 14th, 2015 - Hypoparathyroidism (HypoPT) is a rare (orphan) endocrine disease with low calcium and inappropriately low (insufficient) circulating parathyroid hormone levels, most often in adults secondary to thyroid surgery. Standard treatment is activated vit...

Clinical practice guideline: improving voice outcomes after thyroid surgery.
https://doi.org/10.1177/0194599813487301
Otolaryngology--head and Neck Surgery : Official Journal ... Chandrasekhar SS, Randolph GW et. al.

Jun 13th, 2013 - Thyroidectomy may be performed for clinical indications that include malignancy, benign nodules or cysts, suspicious findings on fine needle aspiration biopsy, dysphagia from cervical esophageal compression, or dyspnea from airway compression. Abo...

see more →

Drugs  117 results see all →

Clinicaltrials.gov  1,843 results

Intraoperative parathyroid hormone measurement facilitates outpatient thyroidectomy in ...
https://doi.org/10.1016/j.amjsurg.2021.02.009
American Journal of Surgery; Obiarinze R, Fazendin J et. al.

Mar 2nd, 2021 - We hypothesize that intraoperative parathyroid hormone (ioPTH) measurement after a total thyroidectomy predicts children at risk for hypoparathyroidism and allow for outpatient procedure. Between 2015 and 2019, we reviewed all patients under the a...

What are the real rates of temporary hypoparathyroidism following thyroidectomy? It is ...
https://doi.org/10.1007/s12020-021-02663-8 10.1007/s13304-017-0475-3 10.1016/j.surg.2014.09.007 10.1007/s12020-019-01858-4 10.1089/thy.2017.0309 10.1530/EJE-15-0628 10.12659/MSM.892867 10.1002/jso.24159 10.1007/s12020-019-02014-8 10.1016/j.anl.2018.04.008 10.1111/j.1445-2197.2010.05633.x 10.1007/s00423-015-1292-0 10.1016/j.ijsu.2016.08.010 10.1186/1477-7819-12-200 10.1007/s00268-012-1809-4 10.1016/j.asjsur.2015.11.005 10.1007/s00268-012-1843-2 10.1007/s12020-018-1601-9 10.1530/EJE-17-0589 10.1016/j.surg.2015.04.041 10.1016/j.ijsu.2015.04.074 10.1007/s00268-014-2571-6 10.1007/s00268-019-04987-z 10.1016/j.jss.2015.04.059 10.1002/hed.23937 10.1177/0194599814521365 10.1016/j.amjsurg.2013.01.038 10.1007/s12020-020-02310-8 10.1016/j.anorl.2013.11.009 10.1016/j.jpedsurg.2019.06.027 10.1016/j.surg.2012.08.056 10.1007/s00268-019-05231-4 10.1016/j.jpedsurg.2017.01.011 10.1016/j.jss.2020.02.018 10.1007/s00268-020-05514-1 10.1016/j.endinu.2018.08.006 10.1007/s00268-019-05125-5 10.1001/jamaoto.2016.3670 10.1007/s00423-016-1386-3 10.1002/bjs.10086 10.1515/jpem-2015-0333 10.1007/s00268-014-2622-z 10.1016/j.amjsurg.2013.11.007 10.1111/j.1445-2197.2005.03435.x 10.1016/j.surg.2017.12.025 10.1007/s00595-020-02065-9
Endocrine Koimtzis GD, Stefanopoulos L et. al.

Mar 2nd, 2021 - Post-operative hypoparathyroidism is the most encountered complication of thyroid surgery and is classified as temporary or permanent. However, its incidence varies greatly in the literature ranging from 0.5% to 65%. This can be mainly attributed ...

Ergocalciferol - ergocalciferol capsule, liquid filled-NuCare Pharmaceuticals, Inc.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=492452d6-2b32-39c0-e054-00144ff8d46c

Feb 22nd, 2021 - Ergocalciferol is indicated for use in the treatment of hypoparathyroidism, refractory rickets, also known as vitamin D resistant rickets, and familial hypophosphatemia.

Renal complications in patients with chronic hypoparathyroidism on conventional therapy...
https://doi.org/10.1007/s11154-020-09613-1 10.1016/j.ecl.2018.07.012 10.1056/NEJMcp0803050 10.1359/jbmr.080803 10.1002/jbmr.1979 10.1002/jbmr.2501 10.1002/jbmr.3368 10.1210/jc.2015-2257 10.7326/0003-4819-151-4-200908180-00135 10.1007/s00467-009-1116-y 10.3389/fped.2018.00098 10.1038/ki.2015.76 10.4158/EP13328.OR 10.1007/s40618-018-0857-5 10.1055/s-0042-118181 10.1210/jc.2016-1477 10.1148/radiol.2221010453 10.2215/CJN.02610319
Reviews in Endocrine & Metabolic Disorders; Gosmanova EO, Houillier P et. al.

Feb 18th, 2021 - A systematic literature review was performed to summarize the frequency and nature of renal complications in patients with chronic hypoparathyroidism managed with conventional therapy. Methodology was consistent with the recommendations outlined i...

see more →

News  113 results

Natpar(a): A Case in Point for Rare Disease Drugs?
https://www.staging.medscape.com/viewarticle/922834

Dec 17th, 2019 - While the recent recall of injectable recombinant parathyroid hormone (PTH) (Natpara, Takeda) in the United States has grabbed the headlines, the situation for patients with chronic hypoparathyroidism who want to take the drug in Europe (where it'...

Natpar(a): A Case in Point for Rare Disease Drugs?
https://www.medscape.com/viewarticle/922834

Dec 17th, 2019 - While the recent recall of injectable recombinant parathyroid hormone (PTH) (Natpara, Takeda) in the United States has grabbed the headlines, the situation for patients with chronic hypoparathyroidism who want to take the drug in Europe (where it'...

Drug Recall in US Causes Hypoparathyroid Patients Extreme Hardship
https://www.medscape.com/viewarticle/921971

Dec 1st, 2019 - The recall of injectable recombinant parathyroid hormone (PTH) (Natpara, Takeda) in the United States over safety concerns about the product is gravely affecting the lives of American patients with severe hypoparathyroidism who need replacement PT...

Parathyroid Hormone Replacement Effective, Safe Long Term
https://www.staging.medscape.com/viewarticle/911357

Apr 3rd, 2019 - NEW ORLEANS — Recombinant human parathyroid hormone 1-84 (rhPTH[1-84]) (Natpara, Shire) was safe and effective over 6 years of continuous use for the treatment of adults with chronic hypoparathyroidism, new research shows. Findings from the long-t...

Parathyroid Hormone Replacement Effective, Safe Long Term
https://www.medscape.com/viewarticle/911357

Apr 3rd, 2019 - NEW ORLEANS — Recombinant human parathyroid hormone 1-84 (rhPTH[1-84]) (Natpara, Shire) was safe and effective over 6 years of continuous use for the treatment of adults with chronic hypoparathyroidism, new research shows. Findings from the long-t...

see more →

Patient Education  5 results see all →